|
|
|
|
Office Locations:
|
1000 Wilson Blvd., Suite 3000
Arlington, VA 22209
Phone: 703-562-4000
| | |
|
|
|
|
|
Consumer Products & Services
Information Technology
Life Sciences & Healthcare
|
|
|
|
Sands Capital Ventures invests in promising businesses in three dynamic, high-growth markets: Life Sciences, Technology, and Global Consumer. The firm is the venture capital affiliate of Sands Capital Management, an investment firm founded in 1992 that manages long-only, concentrated public company portfolios. An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than $59 billion in client assets as of September 30, 2020. Sands' Private Growth strategy targets growth equity investments in highly innovative, mid-late stage technology companies. The firm typically seeks a $25 million to $100 million target investment size per company.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
|
| Name | |
| |
Title | |
Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
|
| Christy Steele | |
| |
Senior Associate | |
| Erin Soule | |
CPA | |
Director of Finance and Operations | |
| Frank Sands | |
CFA | |
CIO and CEO & Co-Founder | |
| Gene Riechers | |
| |
Venture Partner | |
| Ian Ratcliffe | |
| |
Managing Partner | |
|
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
10/20/2022
|
Tellius
|
VA
|
$16,000,000
|
Series B
|
09/06/2022
|
Elephas Biosciences
|
WI
|
$41,500,000
|
Series B
|
07/11/2022
|
Inspirna
|
NY
|
$50,000,000
|
Series D
|
05/26/2022
|
Redbud Brands
|
TX
|
$46,000,000
|
Venture
|
05/24/2022
|
LimaCharlie
|
CA
|
$5,450,000
|
Seed
|
05/17/2022
|
Credo AI
|
CA
|
$12,800,000
|
Series A
|
02/28/2022
|
Selux Diagnostics
|
MA
|
$50,000,000
|
Series C
|
02/10/2022
|
Day Zero Diagnostics
|
MA
|
$21,000,000
|
|
02/04/2022
|
Codoxo
|
GA
|
$20,000,000
|
Series B
|
|
|
|
|
|
|
|
